Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT00818558

The Method ISET (Insulation by Size of Epithelial Tumor Cells)

Conditions: Non Small Cell Lung Cancer

Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 256
Sponsor: Centre Hospitalier Universitaire de Nice

Location: Pr Paul HOFMAN Nice

Summary

The aim of this study is, i) to assess the presence and the frequency of CTC in NSCLC patients undergoing surgery by using cytopathological analysis after their isolation by size (ISET method), and, ii) to correlate the presence of CNHC with pTNM stage, histological subtype, and percentage of tumor cells present into the primary tumors.

Eligibility Criteria

Inclusion Criteria: For the patients: * patient having been operated for a strong suspicion or a suspicion of a malignant tumoral hurt corresponding to a primitive carcinoma not in small cell of the lung For the control subjects: * Tabagical patients (between 10 and 30 packages years) * unhurt of any malignant or mild tumoral pathology or patients that must benefit from a surgical operation for an extract of a hurt lung parenchymateuse for a not tumoral hurt Exclusion Criteria: * Patient with histories of cancer or the other synchronous cancer * Patient with carcinomas with small cells, bronchiolo-alveolar carcinomas, the other types of tumors (lymphomes, sarcomas, etc.). * Patient with neoadditives treatments * Patient according to treatments additives others than protocols codified (in particular, platinum navelbine or gemcitabine platinum) for stages II

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT00818558). StuddyBuddy aggregates publicly available trial information.